亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Is Surgical Thrombo-Embolectomy in Acute Limb Ischemia Still Advantageous in Patients More Than 65 Years of Age?

医学 筋膜切开术 栓子切除术 截肢 缺血 肢体缺血 外科 并发症 死亡率 比例危险模型 回顾性队列研究 内科学 肺栓塞 不利影响
作者
Ali Cemal Düzgün,Ekin İlkeli
出处
期刊:Heart Surgery Forum [Carden Jennings Publishing Co.]
卷期号:24 (6): E988-E995
标识
DOI:10.1532/hsf.4157
摘要

Objective: In this study, we investigated the benefits of using Fogarty balloon catheterization in the treatment of acute leg ischemia with respect to amputation, fasciotomy, and mortality in older patients. Methods: A total of 102 patients age >65 who had a Fogarty thrombo-embolectomy for acute thromboembolic limb ischemia were investigated retrospectively. Patients were evaluated based on Rutherford IIa and IIb criteria and duration of ischemia. Duration of ischemia was divided into 3 categories (as 0 to 4, 4 to 8, and >8 hours) to evaluate the effect of ischemia period on vital parameters and mortality. Analysis with Cox regression showed that 30-day mortality was associated with older age and number of comorbidities such as amputation and fasciotomy. Results: In 102 patients >65 years of age who underwent embolectomy, rates were 7.2% fasciotomy (n = 7) and 13.7% amputation (n = 14), and 10 patients died (9.8%). According to multiple regression analysis, the surgical risk increases 1074 times when each year is added to the chronological age of over 65 years. Conclusion: In a majority of cases, limb salvage can be obtained via simple embolectomy rather than risking intravenous iodinated contrast. Although alternatives in older patients are limited, the Fogarty catheter should be regarded as a first-line treatment because of its ease of use and low complication rate.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
kin发布了新的文献求助10
16秒前
22秒前
24秒前
嘀嘀菇菇发布了新的文献求助10
25秒前
一只小透明呀关注了科研通微信公众号
28秒前
39秒前
科研通AI6.1应助嘀嘀菇菇采纳,获得10
39秒前
46秒前
47秒前
所所应助冷酷一曲采纳,获得10
52秒前
59秒前
老实蛋挞完成签到,获得积分10
1分钟前
老实蛋挞发布了新的文献求助10
1分钟前
1分钟前
1分钟前
orixero应助老实蛋挞采纳,获得10
1分钟前
ding应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
宁过儿完成签到,获得积分10
2分钟前
2分钟前
2分钟前
2分钟前
瓜兮兮CYY发布了新的文献求助10
2分钟前
Cope完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
2分钟前
kin发布了新的文献求助10
2分钟前
2分钟前
djdh完成签到 ,获得积分10
2分钟前
xiaohu完成签到 ,获得积分10
2分钟前
皮皮完成签到 ,获得积分10
2分钟前
完美世界应助姿势采纳,获得80
2分钟前
3分钟前
3分钟前
姿势发布了新的文献求助80
3分钟前
3分钟前
JamesPei应助科研通管家采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Les Mantodea de guyane 2500
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 2000
Standard: In-Space Storable Fluid Transfer for Prepared Spacecraft (AIAA S-157-2024) 1000
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5950235
求助须知:如何正确求助?哪些是违规求助? 7132246
关于积分的说明 15917450
捐赠科研通 5083723
什么是DOI,文献DOI怎么找? 2733027
邀请新用户注册赠送积分活动 1694078
关于科研通互助平台的介绍 1615990